{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:44:56Z","timestamp":1760607896590,"version":"3.43.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1999,8,1]],"date-time":"1999-08-01T00:00:00Z","timestamp":933465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,8,1]],"date-time":"1999-08-01T00:00:00Z","timestamp":933465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[1999,8]]},"DOI":"10.1023\/a:1008907001042","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T12:46:35Z","timestamp":1040561195000},"page":"105-112","source":"Crossref","is-referenced-by-count":17,"title":["Clinical Implications of Elevated PAI-1 Revisited: Multiple Arterial Thrombosis in a Patient with Essential Thrombocythemia and Elevated Plasminogen Activator Inhibitor-1 (PAI-1) Levels with a Review of the Literature"],"prefix":"10.1007","volume":"8","author":[{"given":"Sandra L.","family":"Senno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liberto","family":"Pechet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"231135_CR1","first-page":"241","volume":"35","author":"L. Harker","year":"1998","unstructured":"Harker L. Platelets in thrombotic disorders: Quantitative and qualitative platelet disorders predisposing to arterial thrombosis. Semin Hematolol 1998;35:241\u2013252.","journal-title":"Semin Hematolol"},{"key":"231135_CR2","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/1097-0142(19910601)67:11<2926::AID-CNCR2820671136>3.0.CO;2-3","volume":"67","author":"M Colombi","year":"1991","unstructured":"Colombi M, Radaelli F, Zocchi L, et al. Thrombotic and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patients. Cancer 1991;67:2926\u20132930.","journal-title":"Cancer"},{"key":"231135_CR3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1097-0142(19900801)66:3<549::AID-CNCR2820660324>3.0.CO;2-6","volume":"66","author":"P. S. Fenaux","year":"1990","unstructured":"Fenaux P SM, Caulier MT, Lai JL, et al. Clinical course of essential thrombocythemia in 147 cases. Cancer 1990;66: 549\u2013556.","journal-title":"Cancer"},{"key":"231135_CR4","first-page":"200","volume":"35","author":"L Cripe","year":"1998","unstructured":"Cripe L, Hromas R. Malignant disorders of megakaryocytes. Semin Hematol 1998;35:200\u2013209.","journal-title":"Semin Hematol"},{"key":"231135_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0049-3848(98)00005-X","volume":"90","author":"E Posan","year":"1998","unstructured":"Posan E, Ujj G, Kiss A, et al. Reduced in vitro clot lysis and release of more active platelet PAI-1 in polycythemia vera and essential thrombocythemia. Thromb Res 1998;90:51\u201356.","journal-title":"Thromb Res"},{"key":"231135_CR6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2141.1993.tb08272.x","volume":"83","author":"KV. Watson","year":"1993","unstructured":"Watson KV. Vascular complications of essential thrombocythemia: A link to cardiovascular risk factors. Br J Haematol 1993;83:198\u2013203.","journal-title":"Br J Haematol"},{"key":"231135_CR7","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/1097-0142(19861201)58:11<2440::AID-CNCR2820581115>3.0.CO;2-Y","volume":"58","author":"S Bellucci","year":"1986","unstructured":"Bellucci S, Tobelem G, Flandrin G, et al. Essential thombocythemia. Cancer 1986;58:2440\u20132447.","journal-title":"Cancer"},{"key":"231135_CR8","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1161\/01.CIR.94.9.2057","volume":"94","author":"I Juhan-Vague","year":"1996","unstructured":"Juhan-Vague I, Pyke SDM, Alessi MC, et al. Fibrinolytic factor and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation 1996;94:2057\u20132063.","journal-title":"Circulation"},{"key":"231135_CR9","first-page":"259","volume":"378","author":"H Pappot","year":"1995","unstructured":"Pappot H, Gardsvoll H, Romer J, et al. Plasminogen activator inhibitor type 1 in cancer: Therapeutic and prognostic implications. Biol Chem 1995;378:259\u2013267.","journal-title":"Biol Chem"},{"key":"231135_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0049-3848(94)90226-7","volume":"75","author":"JA Cancelas","year":"1994","unstructured":"Cancelas JA, Garcia-Avello A, Garcia-Frade LJ. High plasma level of plasminogen activator inhibitor 1 (PAI-1) in polycythemia vera and essential thrombocythemia are associated with thrombosis. Thromb Res 1994;75:513\u2013520.","journal-title":"Thromb Res"},{"key":"231135_CR11","first-page":"38","volume":"23","author":"M Bazzan","year":"1993","unstructured":"Bazzan M, Tamponi G, Gallo E, et al. Fibrinolytic imbalance in essential thrombocythemia: A role of platelets. Haemostasis 1993;23:38\u201344.","journal-title":"Haemostasis"},{"key":"231135_CR12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-0038-1651056","volume":"57","author":"G Urden","year":"1987","unstructured":"Urden G, Chmielewska J, Carlsson T, et al. Immunological relationship between PAI-1 from different sources. Thromb Haemost 1987;57:29.","journal-title":"Thromb Haemost"},{"key":"231135_CR13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0021-9150(92)90014-8","volume":"95","author":"S Dawson","year":"1992","unstructured":"Dawson S, Henney A. The status of PAI-1 as a risk factor for arterial and thrombotic disease: A review. Atherosclerosis 1992;95:105\u2013117.","journal-title":"Atherosclerosis"},{"key":"231135_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.ATV.18.1.1","volume":"18","author":"D Loskutoff","year":"1998","unstructured":"Loskutoff D, Smad F. The adipocyte and hemostatic balance in obesity. Arterioscler Thromb Vasc Biol 1998;18:1\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"231135_CR15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2141.1990.tb07796.x","volume":"75","author":"AJ Simpson","year":"1990","unstructured":"Simpson AJ, Booth NA, Moore NR. The platelet and plasma pools of plasminogen activator inhibitor (PAI-1) vary independently in disease. Br J Haematol 1990;75:543\u2013548.","journal-title":"Br J Haematol"},{"key":"231135_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0049-3848(94)90204-6","volume":"76","author":"A Takada","year":"1994","unstructured":"Takada A, Takada Y, Urano T. The physiological aspects of fibrinolysis. Thromb Res 1994;76:1\u201331.","journal-title":"Thromb Res"},{"key":"231135_CR17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1055\/s-0038-1657569","volume":"78","author":"SE Humphries","year":"1997","unstructured":"Humphries SE, Panahloo A, Montgomery HE, et al. Geneenvironment interaction in the determination of levels of haemostatic variables involved in the thrombosis and fibrinolysis. Thromb Haemost 1997;78:457\u2013461.","journal-title":"Thromb Haemost"},{"key":"231135_CR18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-0038-1642655","volume":"74","author":"B. Winman","year":"1995","unstructured":"Winman B. Plasminogen activator inhibitor 1 (PAI-1) in plasma: Its role in thrombotic disease. Thromb Haemost 1995;74:71\u201376.","journal-title":"Thromb Haemost"},{"key":"231135_CR19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1055\/s-0038-1646895","volume":"62","author":"TL Lindahl","year":"1989","unstructured":"Lindahl TL, Sigurdarttir O, Winman B. Stability of plasminogen activator-1 (PAI-1). Thromb Haemost 1989;62:748\u2013751.","journal-title":"Thromb Haemost"},{"key":"231135_CR20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/00365519709084594","volume":"57","author":"A Nordenham","year":"1997","unstructured":"Nordenham A, Wiman B. Plasminogen activator inhibitor (PAI-1) content in platelets from healthy individuals genotyped for the 4G\/5G polymorphism in the PAI-1 gene. Scand J Clin Lab Invest 1997;57:453\u2013461.","journal-title":"Scand J Clin Lab Invest"},{"key":"231135_CR21","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1182\/blood.V90.5.1874","volume":"90","author":"M Van Meijer","year":"1997","unstructured":"Van Meijer M, Smilde A, Tans G, et al. The suicide reaction between plasminogen activator inhibitor-1 and thrombin is regulated by cofactors vitronectin and heparin. Blood 1997; 90:1874\u20131882.","journal-title":"Blood"},{"key":"231135_CR22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/01.ATV.13.5.669","volume":"13","author":"BA Konkle","year":"1993","unstructured":"Konkle BA, Schick PA, Xiabli H, et al. Plasminogen activator inhibitor-1 mRNA is expressed in platelets and megakaryocytes and megakaryoblastic cell line CHRF-288. Arterioscler Thromb 1993;13:669\u2013674.","journal-title":"Arterioscler Thromb"},{"key":"231135_CR23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1182\/blood.V83.2.351.351","volume":"83","author":"WP Fay","year":"1994","unstructured":"Fay WP, Eitzman DT, Shapiro AD, et al. Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and independent mechanisms. Blood 1994;83: 351\u2013356.","journal-title":"Blood"},{"key":"231135_CR24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/01.ATV.18.1.20","volume":"18","author":"P Eriksson","year":"1998","unstructured":"Eriksson P, Nilsson L, Karpe F, et al. Very-low density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene. Arterioscler Thromb Vasc Biol. 1998;18:20\u201326.","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"231135_CR25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1432-1033.1988.tb14320.x","volume":"176","author":"L Starnberg","year":"1988","unstructured":"Starnberg L, Lawrence D, Ny T. The organization of the human plasminogen activator inhibitor-1 gene. Implications on the evolution of the serine-protease inhibitor family. Eur J Biochem 1988;176:609\u2013616.","journal-title":"Eur J Biochem"},{"key":"231135_CR26","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1055\/s-0037-1615395","volume":"80","author":"MT Sartori","year":"1998","unstructured":"Sartori MT, Winman B, Veltore S, et al.4G\/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep venous thrombosis. Thromb Haemost 1998;80:956\u2013960.","journal-title":"Thromb Haemost"},{"key":"231135_CR27","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0026-0495(97)90150-5","volume":"46","author":"CJ Glueck","year":"1997","unstructured":"Glueck CJ, Fontaine RN, Gupta A, et al. Myocardial infarction in a 35-year-old man with homocysteinemia, high plasminogen activator inhibitor activity and resistance to activated protein C. Metabolism 1997;46:1470\u20131472.","journal-title":"Metabolism"},{"key":"231135_CR28","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.ATV.18.4.562","volume":"18","author":"M Margaglione","year":"1998","unstructured":"Margaglione M, Cappusi G, d'Addedda, et al. PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: Relation to environment and genetic determinants. Arterscler Thromb Vasc Biol 1998;18:562\u2013567.","journal-title":"Arterscler Thromb Vasc Biol"},{"key":"231135_CR29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2796.1990.tb00157.x","volume":"227","author":"K Landin","year":"1990","unstructured":"Landin K, Tengborn L, Smith V. Elevated fibrinogen and plasminogen activator (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med 1990;227:273\u2013278.","journal-title":"J Intern Med"},{"key":"231135_CR30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF00403280","volume":"34","author":"I Juhan-Vague","year":"1991","unstructured":"Juhan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor levels: A possible link between insulin resistance and artherothrombosis. Diabetologia 1991;34:457\u2013462.","journal-title":"Diabetologia"},{"key":"231135_CR31","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1161\/01.CIR.97.22.2213","volume":"97","author":"BE Sobel","year":"1998","unstructured":"Sobel BE, Woodcock-Mitchell J, Schneider DJ. Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients. Circulation 1998;97:2213\u20132221.","journal-title":"Circulation"},{"key":"231135_CR32","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/bmj.308.6935.1003","volume":"308","author":"HFJ Hendrinks","year":"1994","unstructured":"Hendrinks HFJ, Veenstgra J, Velthuis-te Wierik EJM, et al. Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. Br Med J 1994;308:1003\u20131005.","journal-title":"Br Med J"},{"key":"231135_CR33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1055\/s-0038-1646614","volume":"61","author":"G Pralong","year":"1989","unstructured":"Pralong G, Calandra T, Glauser MP, et al. Plasminogen activator inhibitor-1: A new prognostic marker in septic shock. Thromb Haemost 1989;61:459\u2013462.","journal-title":"Thromb Haemost"},{"key":"231135_CR34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s001250050868","volume":"41","author":"P Eriksson","year":"1998","unstructured":"Eriksson P, Reynisdottir S, Lunnquist F, et al. Adipose tissue secretion of plasminogen activator inhibitor-1 in nonobese and obese individuals. Diabetologia 1998;41:65\u201371.","journal-title":"Diabetologia"},{"key":"231135_CR35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0168-8227(96)01286-7","volume":"33","author":"R Testa","year":"1996","unstructured":"Testa R, Bonfigli AR, Piantanelli L, et al. Relationship between plasminogen activation inhibitor type-1 plasma levels and the lipoprotein (a) concentrations in non-insulin dependent diabetes mellitus. Diabetes Res Clin Pract 1996;33: 111\u2013118.","journal-title":"Diabetes Res Clin Pract"},{"key":"231135_CR36","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1161\/01.CIR.91.4.1175","volume":"91","author":"PM Ridker","year":"1995","unstructured":"Ridker PM, Gabourg CL, Conlin PR, et al. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation 1995;91:1175\u20131181.","journal-title":"Circulation"},{"key":"231135_CR37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0049-3848(97)00222-3","volume":"88","author":"TK Makris","year":"1997","unstructured":"Makris TK, Tsoukala C, Krespi P, et al. Haemostasis balance disorders in patients with essential hypertension. Thromb Res 1997;88:99\u2013107.","journal-title":"Thromb Res"},{"key":"231135_CR38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.HYP.31.1.321","volume":"31","author":"H Tomiyama","year":"1998","unstructured":"Tomiyama H, Kimura Y, Mitsuashi H, et al. Relationship between endothelial function and fibrinolysis in early hypertension. Hypertension 1998;31:321\u2013327.","journal-title":"Hypertension"},{"key":"231135_CR39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1182\/blood.V69.2.381.381","volume":"69","author":"ED Sprengers","year":"1987","unstructured":"Sprengers ED, Kluft C. Plasminogen activator inhibitor. Blood 1987;69:381\u201338.","journal-title":"Blood"},{"key":"231135_CR40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0021-9150(97)00191-3","volume":"136","author":"N Iwai","year":"1998","unstructured":"Iwai N, Shimioke H, Nakamura Y. The 4G\/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes. Atherosclerosis 1998;136:109\u2013114.","journal-title":"Atherosclerosis"},{"issue":"Suppl","key":"231135_CR41","first-page":"C39","volume":"19","author":"W. Koenig","year":"1998","unstructured":"Koenig W. Haemostatic risk factors for cardiovascular diseases. Eur Heart J 1998;19(Suppl):C39\u2013C43.","journal-title":"Eur Heart J"},{"key":"231135_CR42","first-page":"177","volume":"23","author":"S Murphy","year":"1986","unstructured":"Murphy S, Iland H, Rosenthal D, et al. Essential thrombocythemia: An interim report from the Polythemia Study Group. Semin Haematol 1986;23:177\u2013182.","journal-title":"Semin Haematol"},{"key":"231135_CR43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ajh.2830320203","volume":"32","author":"MG Conlan","year":"1989","unstructured":"Conlan MG, Haire WD. Low protein S in essential thrombocythemia with thrombosis. Am J Hematol 1989;32;88\u201393.","journal-title":"Am J Hematol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1008907001042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1008907001042\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1008907001042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T07:23:43Z","timestamp":1754637823000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1008907001042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,8]]}},"alternative-id":["231135"],"URL":"https:\/\/doi.org\/10.1023\/a:1008907001042","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"type":"print","value":"0929-5305"},{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[1999,8]]}}}